Document is current
Any future updates will be listed below
-
Authors
Mirus, Martin
Dietze, Anna
Tiebel, Oliver
Beyer-Westendorf, Jan
Grottke, Oliver
Tesch, Falko
Spieth, Peter Markus
Heubner, Lars
-
Funding
Funding for this research was provided by:
Technische Universität Dresden
- License Information
-
More Information
Article History
Received: 24 January 2026
Accepted: 18 March 2026
First Online: 24 March 2026
Declarations
:
: The study was designed in accordance with the Declaration of Helsinki. Ethical approval was obtained from the Ethics Committee of the Technische Universität Dresden (BO-EK-374072021). The requirement for informed consent was waived by the Dresden University Ethics Committee due to the observational design and use of de-identified data.
: Not applicable. No individual patient data or identifying information are included in this manuscript.
: J.B.-W. has received honoraria and institutional research support from Alexion/AstraZeneca, Bayer AG, Daiichi Sankyo, Leo Pharma, Norgine, Takeda and Pfizer. O.G. has received research funding, honoraria for lectures or consultancy support from Astra Zeneca, Alexion, Alvereon, Bayer AG, Biotest, Boehringer Ingelheim, CSL Behring, Octapharma, Novo Nordisk, Nycomed, Portola, Pfizer, Sanofi, Takeda, Werfen, DFG (Germany), and BMBF (Germany). LH received honorary for advisory boards from TAKEDA and AstraZeneca as well as honorary for lectures from AstraZeneca, CSL Behring, Werfen and Octapharma. The other authors declare no conflict of interest.
